ASTONEA LABS LIMITED · CashKonnect

About

Astonea Labs Limited manufactures and markets pharmaceutical and cosmetic products under the Glow Up, Avicel, and Regero brand names in India and internationally. The company offers pharmaceutical products, including generics, OTC products, specialty therapeutics, nutraceuticals, and biosimilars, as well as cosmetic and personal care products, such as skincare, haircare, anti-aging, ethical, and organic cosmetic lines. It offers its products in tablets, capsules, softgels, soaps, oral and external powders, ointments, aerosols, creams, and lotions, as well as toothpastes and mouthwashes. Astonea Labs Limited was incorporated in 2017 and is based in Panchkula, India.

Quarterly Results

No quarterly results synced yet for this stock.

Data is backfilled from screener.in — check back soon.

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Sales	148.00	98.00	80.00	67.00	30.00
Expenses	134.00	82.00	68.00	60.00	24.00
Operating Profit	14.00	15.00	12.00	7.00	6.00
OPM %	9.00	16.00	15.00	11.00	19.00
Other Income	1.00	0.00	0.00	0.00	0.00
Interest	3.00	4.00	3.00	2.00	2.00
Depreciation	5.00	5.00	4.00	4.00	4.00
Profit before tax	6.00	7.00	5.00	1.00	1.00
Tax %	20.00	24.00	24.00	39.00	57.00
Net Profit	5.00	5.00	4.00	1.00	0.00
EPS in Rs	4.30	6.93	5.36	1.68	0.62
Dividend Payout %	0.00	0.00	0.00	0.00	0.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Equity Capital	11.00	8.00	8.00	4.00	4.00
Reserves	47.00	11.00	4.00	4.00	3.00
Borrowings	43.00	53.00	42.00	36.00	30.00
Other Liabilities	46.00	32.00	26.00	20.00	16.00
Total Liabilities	146.00	103.00	81.00	64.00	53.00
Fixed Assets	31.00	26.00	22.00	21.00	21.00
CWIP	8.00	4.00	2.00	0.00	0.00
Investments	6.00	0.00	0.00	0.00	0.00
Other Assets	101.00	73.00	57.00	44.00	32.00
Total Assets	146.00	103.00	81.00	64.00	53.00

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Cash from Operating Activity	-14.00	9.00	8.00	-1.00	-5.00
Cash from Investing Activity	-20.00	-11.00	-8.00	-3.00	-3.00
Cash from Financing Activity	34.00	2.00	0.00	4.00	8.00
Net Cash Flow	0.00	0.00	-1.00	0.00	0.00
Free Cash Flow	-28.00	-2.00	0.00	-4.00	-8.00
CFO/OP %	-88.00	70.00	71.00	-9.00	-75.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Debtor Days	129.00	142.00	116.00	104.00	235.00
Inventory Days	125.00	161.00	161.00	121.00	136.00
Days Payable	150.00	144.00	149.00	128.00	273.00
Cash Conversion Cycle	103.00	159.00	128.00	97.00	98.00
Working Capital Days	74.00	22.00	28.00	33.00	98.00
ROCE %	11.00	17.00	17.00	8.00	—